Header Logo

Connection

ABDUL DIWAN to Melanoma

Back to Details
This is a "connection" page, showing publications ABDUL DIWAN has written about Melanoma.
ABDUL DIWAN
Connection Strength
2.822
Melanoma
  1. "Puffy shirt appearance": Cell crowding at low magnification may represent nevoid melanoma. J Cutan Pathol. 2019 Nov; 46(11):805-809.
    View in: PubMed
    Score: 0.368
  2. Approach to moderately dysplastic nevi with positive histologic margins. J Am Acad Dermatol. 2017 11; 77(5):e147.
    View in: PubMed
    Score: 0.327
  3. Reply: Do moderately dysplastic nevi with positive histologic margins need to be reexcised? J Am Acad Dermatol. 2017 09; 77(3):e85.
    View in: PubMed
    Score: 0.323
  4. Nevoid melanoma. Clin Lab Med. 2011 Jun; 31(2):243-53.
    View in: PubMed
    Score: 0.210
  5. Atypical histologic and immunohistochemical findings in melanocytic nevi after liquid nitrogen cryotherapy. J Am Acad Dermatol. 2009 Aug; 61(2):341-5.
    View in: PubMed
    Score: 0.181
  6. Lack of maturation with anti-leptin receptor antibody in melanoma but not in nevi. Mod Pathol. 2009 Jan; 22(1):103-6.
    View in: PubMed
    Score: 0.174
  7. Human melanoma cells express functional receptors for thyroid-stimulating hormone. Endocr Relat Cancer. 2006 Dec; 13(4):1269-77.
    View in: PubMed
    Score: 0.154
  8. Surgical specimen handling for conjunctival melanoma: implications for tumor thickness determination and sentinel lymph node biopsy. Ophthalmic Plast Reconstr Surg. 2006 May-Jun; 22(3):238-9.
    View in: PubMed
    Score: 0.147
  9. Nuclear expression of the antiapoptotic protein survivin in malignant melanoma. Cancer. 2006 Mar 01; 106(5):1123-9.
    View in: PubMed
    Score: 0.146
  10. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol. 2020 03; 33(3):496-513.
    View in: PubMed
    Score: 0.092
  11. A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma. Melanoma Res. 2012 Aug; 22(4):294-301.
    View in: PubMed
    Score: 0.057
  12. Prognostic factors for melanoma in children and adolescents: a clinicopathologic, single-center study of 137 Patients. Cancer. 2010 Sep 15; 116(18):4334-44.
    View in: PubMed
    Score: 0.050
  13. Promotion of melanoma growth by the metabolic hormone leptin. Oncol Rep. 2010 Apr; 23(4):901-7.
    View in: PubMed
    Score: 0.048
  14. Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival. J Cutan Pathol. 2009 Nov; 36(11):1157-63.
    View in: PubMed
    Score: 0.045
  15. Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer. 2008 Sep 02; 99(5):734-40.
    View in: PubMed
    Score: 0.043
  16. Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment. Melanoma Res. 2008 Aug; 18(4):241-5.
    View in: PubMed
    Score: 0.043
  17. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008 Sep 10; 26(26):4296-303.
    View in: PubMed
    Score: 0.043
  18. Cellular blue nevi of the eyelid: A possible diagnostic pitfall. J Am Acad Dermatol. 2008 Feb; 58(2):257-60.
    View in: PubMed
    Score: 0.042
  19. Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Clin Cancer Res. 2007 Aug 15; 13(16):4817-24.
    View in: PubMed
    Score: 0.040
  20. Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions. J Cutan Pathol. 2007 Mar; 34(3):220-5.
    View in: PubMed
    Score: 0.039
  21. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clin Cancer Res. 2006 Nov 15; 12(22):6709-15.
    View in: PubMed
    Score: 0.038
  22. Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec). J Cutan Pathol. 2006 Apr; 33(4):280-5.
    View in: PubMed
    Score: 0.037
  23. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms. J Cutan Pathol. 2005 Sep; 32(8):533-6.
    View in: PubMed
    Score: 0.035
  24. Expression of thyrotropin-releasing hormone by human melanoma and nevi. Clin Cancer Res. 2004 Aug 15; 10(16):5531-6.
    View in: PubMed
    Score: 0.033
  25. Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions. Mod Pathol. 2004 Jul; 17(7):811-8.
    View in: PubMed
    Score: 0.032
  26. HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: a case report. J Cutan Pathol. 2004 Mar; 31(3):284-6.
    View in: PubMed
    Score: 0.032
  27. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions. J Cutan Pathol. 2003 Nov; 30(10):599-605.
    View in: PubMed
    Score: 0.031
  28. Immunohistochemical expression of S100A6 in cellular neurothekeoma: clinicopathologic and immunohistochemical analysis of 31 cases. Am J Dermatopathol. 2009 Jul; 31(5):419-22.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.